John Hodgman has joinedAerogen(Mountain View, California) as president and CEO. Jane Shaw, PhD, has resigned as CEO, and effective June 30, will resign as chairman of the board. Aerogen board member and BioMarin Pharmaceutical CEO Jean-Jacques Bienaime will become lead director of Aerogen. Hodgman most recently was president and CEO of Cygnus and served as that company’s chairman of the board for the last six years. Aerogen, a specialty pharmaceutical company, develops products based on its OnQ Aerosol Generator technology to improve the treatment of respiratory disorders in the acute care setting.

Anahita Villafane was named CFO of Creative Computer Applications (CCA; Calabasas, California), replacing Steven Besbeck, who has resigned that post. Villafane previously served as the company’s controller and chief accounting officer. CCA is a healthcare information technology and service provider.

Alex Milstein, MD, has been named vice president of clinical research at MacroPore Biosurgery (San Diego). Prior to joining MacroPore, Milstein held several senior positions in clinical development, most recently with Medtronic and Guidant. MacroPore Biosurgery specializes in the discovery and development of regenerative medicine therapies.

Eugene Seymour, MD, has joined Nanoviricides (West Haven, Connecticut) as CEO and chairman of the board. Seymour founded SDS, which makes the Hema-Strip rapid HIV antibody blood test, and a non-profit foundation that provided testing and training programs for health workers in Asia and Africa. He has also served as a consultant to the UN Global Program on AIDS. Most recently, he was director of strategic alliances at a medical education startup,, that was later acquired and is now named Nanoviricides, recently purchased by (Medical Device Daily, June 8, 2005), is creating special-purpose nanomaterials for viral therapy.

John Jensen has joined Pacific Biometrics (Seattle) as controller. Pacific Biometrics provides specialized central laboratory and contract research services to support pharmaceutical and diagnostic manufacturers conducting human clinical trial research.

Mary Jo Gorman, MD, has been voted president-elect of the Society of Hospital Medicine (SHM; Philadelphia), a medical society representing hospitalists – physicians whose primary focus is the care of hospitalized patients. Gorman, chief medical officer of IPC-The Hospitalist Company (North Hollywood, California), has been a member of SHM’s board of directors since 2002 and most recently was chair of the society’s public policy committee. She has been a practicing hospitalist since 1997, when she founded the first hospitalist practice in St. Louis. Her original group merged into IPC in 1999.